Medicine
Secuado 5.7 mg/day extended-release film
Secuado 5.7 mg/day extended-release film is a prescription medicine containing Asenapine for transdermal use, marketed by Noven Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature 20°C to 25°C (68°F to 77°F) with excursions…
Key facts
- Active ingredient (INN)
- Asenapine
- Brand
- Secuado
- Strength
- 5.7 mg/day
- Dosage form
- Extended-release film
- Route
- Transdermal
- Packs
- 30 pouches, 7 pouches
- Marketing authorisation holder
- Noven Therapeutics
- Manufacturer
- Noven Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store at room temperature 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (between 59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AH05 Asenapine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 February 2020
- Identifiers
- RxCUI 2261741, 2261750, 2261758 +3DailyMed set ID 685eaf44-5944-4f38-afba-0a4fc0b3462bNDC 68968-0173Application NDA212268
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 pouch in 1 carton / 1 d in 1 pouch | 68968-0173-3 | Noven Therapeutics | 12 February 2020 |
| 7 pouch in 1 carton / 1 d in 1 pouch | 68968-0173-7 | Noven Therapeutics | 12 February 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Asenapine
Clinical summary
Asenapine is an atypical antipsychotic indicated for schizophrenia in adults Bipolar I disorder, among other approved uses. It is available as sublingual tablets and extended-release films for transdermal use. MedsAcross supplies Asenapine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AsenapineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SAPHRIS prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Sycrest: European public assessment report (EPAR) · European Medicines Agency
Need Secuado 5.7 mg/day extended-release film for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.